Table 4 Secondary outcomes chemotherapy-associated toxicity parameter list
Secondary outcome parameter: | |
|---|---|
Neutrophil granulocytes | |
Neutropenia, number of days | |
Red blood cell transfusion | |
Transfusion of thrombocyte concentrates | |
Fever, maximum temperature | |
Antibiotics | |
Antimycotics/antifungals | |
Catheter infection | |
Number of C-reactive protein values/measurements above the norm | |
Number of C-reactive protein Values threefold above the norm | |
Maximum CRP value | |
Days with fever above 38,5 °C | |
Nausea | |
Emesis | |
Stomatitis | |
Number of days with stomatitis | |
Abdominal pain/cramping | |
Gastritis | |
Obstipation | |
Diarrhea episodes per day | |
Pancreas ultrasonography/sonography | |
Thrombosis | |
Creatinine clearance | |
Steroid diabetes | |
Cushing syndrome | |
Arrhythmia | |
Cardiac function | |
Echocardiography, left ventricular shortening fraction | |
Pain | |
Central neurotoxicity | |
Fatigue | |
Peripheral neurotoxicity | |
Mood swings: depression | |
Mood swings: anxiety | |
Mood swings: euphoria | |
General wellbeing | |
Skin alterations | |
Osteonecrosis | |
Delay in onset of the last treatment block | |
Hemoglobin | |
Thrombocytes | |
Leucocytes maximum value | |
Leucocytes minimum value | |
CRP maximum value | |
Alpha lipase | |
Glucose | |
Aspartat amino transferase (AST, ASAT) | |
Alanin amino transferase (ALT, ALAT) | |
Bilirubin | |
Creatinine | |
Amylase | |
Fibrinogen | |
Antithrombin III (AT-III) | |
Proteinuria | |
prothrombin time (PTT) |